The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review
Open Access
- 4 October 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 30 (6), 676-681
- https://doi.org/10.1038/s41431-021-00970-2
Abstract
Since 2019, England, France and Germany have started offering NIPT as a publicly funded second-tier test for common chromosomal aneuploidies (trisomy 21, 18 and/or 13). Despite these benefits, the introduction of NIPT into routine prenatal care also raises a number of ethical concerns. In this paper, we analyse how these issues are discussed differently across countries, echoing the different socio-political particularities and value-systems that shape the use and regulation of NIPT in a specific country. The international comparison between England, France and Germany shows how each country defines the principle of reproductive autonomy and weighs it against other principles and values, such as, human dignity, disability rights and the duty of care of health professionals. In terms of methodology, our literature review focuses on arguments and regulations of prenatal testing and reproductive choices (specifically on NIPT), through the investigation of regulatory, parliamentary, scientific, medical, association, institutional and media sources. The comparative review helps to better understand ethical questions discussed with regard to NIPT, and, more broadly, to prenatal genomic testing, and the limits associated with reproductive autonomy in the three countries studied. Whereas reproductive autonomy is valued in each country, it is understood and implemented differently depending on the socio-cultural context, and on what other principles are evoked and how they are defined.Keywords
Funding Information
- RCUK | Economic and Social Research Council (ES/T00908X/1, ES/T00908X/1)
This publication has 27 references indexed in Scilit:
- Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnanciesUltrasound in Obstetrics & Gynecology, 2015
- Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social IssuesAnnual Review of Genomics and Human Genetics, 2015
- Non-invasive prenatal testing: a review of international implementation and challengesInternational Journal of Women's Health, 2015
- For Your Interest? The Ethical Acceptability of Using Non‐Invasive Prenatal Testing to Test ‘Purely for Information’Bioethics, 2014
- Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screeningEuropean Journal of Human Genetics, 2014
- Prenatal diagnosis as a tool and support for eugenics: myth or reality in contemporary French society?Medicine, Health Care and Philosophy, 2012
- Advance Directives in English and French Law: Different Concepts, Different Values, Different SocietiesHealth Care Analysis, 2012
- Prenatal screening for Down syndrome: women's involvement in decision‐making and their attitudes to screeningPrenatal Diagnosis, 2009
- How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French studyPrenatal Diagnosis, 2007
- Post-diagnostic abortion in Germany: reproduction gone awry, again?Social Science & Medicine (1982), 2003